STOCK TITAN

Windward Bio grants director 100,000 stock units

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Sandip Kapadia, a director of WINDWARD BIO GROUP AG (WWB), was granted 100,000 restricted stock units on November 16, 2026, and 22,675 share options on November 12, 2026. The options have a $17 exercise price and expire November 12, 2036. Both awards are subject to his continuous service on applicable vesting dates.

Insider Kapadia Sandip
Role Director
Type Security Shares Price Value
Grant/Award Common Shares F1 100,000 $0.00 $0.00
Grant/Award Share Option (right to buy) F2 22,675 $0.00 $0.00
Holdings After Transaction: Share Option (right to buy) — 22,675 options (Direct); Common Shares — 100,000 shares (Direct)
Holdings Before and After: Share Option (right to buy), 0 to 22,675 options (Direct); Common Shares, 0 to 100,000 shares (Direct)
Footnotes (2)
  1. F1. One quarter (1/4th) of the RSU will vest on May 11, 2027, and the remainder will vest in twelve substantially equal installments on each subsequent May 20, August 20, November 20 and February 20, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
  2. F2. This option will vest in 12 substantially equal monthly installments on the last day of the relevant month commencing on December 31, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
Restricted stock units awarded 100,000 RSUs Awarded to Sandip Kapadia on November 16, 2026; reported directly after the award.
Share options awarded 22,675 options Awarded to Sandip Kapadia on November 12, 2026; reported directly after the award.
Exercise price $17 per share Price for the share options.
Option expiration date November 12, 2036 Expiration date for the share options.
First RSU vesting date May 11, 2027 One quarter of the RSU is scheduled to vest on this date, subject to continuous service.
RSU technical
"One quarter (1/4th) of the RSU will vest"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
substantially equal installments technical
"the remainder will vest in twelve substantially equal installments"
exercise price financial
"Share Option (right to buy)"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How do WWB director Sandip Kapadia’s 100,000 RSUs vest?

One quarter (1/4th) of the RSU is scheduled to vest on May 11, 2027, and the remainder in 12 substantially equal installments on each subsequent May 20, August 20, November 20 and February 20, subject to his continuous service on each vesting date.

When do Sandip Kapadia’s WWB options vest?

The 22,675 options vest in 12 substantially equal monthly installments on the last day of the relevant month, beginning December 31, 2026, subject to his continuous service on each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kapadia Sandip

(Last)(First)(Middle)
C/O WINDWARD BIO GROUP AG
AESCHENPLATZ 6

(Street)
BASEL4052

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
WINDWARD BIO GROUP AG [ WWB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares11/16/2026A100,000(1)A$0100,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Share Option (right to buy)$1711/12/2026A22,675 (2)11/12/2036Common Shares22,675$022,675D
Explanation of Responses:
1. One quarter (1/4th) of the RSU will vest on May 11, 2027, and the remainder will vest in twelve substantially equal installments on each subsequent May 20, August 20, November 20 and February 20, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
2. This option will vest in 12 substantially equal monthly installments on the last day of the relevant month commencing on December 31, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
/s/ Scott Applebaum, Attorney-in-Fact11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading